Logo ActuIA ActuIA

AI news from France

Français Español Italiano Deutsch Nederlands Română Polski Português العربية Türkçe Українська 中文 日本語 한국어
PUBLIER
Home Latest news
Explorer
Topics
AI Market Artificial intelligence research Commercial product Digital transformation Ethics of Artificial Intelligence Evolution of Society Security Tool for Data Scientists Training in artificial intelligence
Industries
Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport
Par thème
AI Market Artificial intelligence research Commercial product Digital transformation Ethics of Artificial Intelligence Evolution of Society Security Tool for Data Scientists Training in artificial intelligence
Par secteur
Company Culture Defense Education Finance Fundamental Research Health - medicine Industry Insurance Justice Marketing Media Risk Prevention Social networks Telecommunications Transport
Langue

MAbSilico

MAbSilico est un éditeur de logiciels ayant la vision d'accélérer le développement d'anticorps thérapeutiques en utilisant des solutions pilotées par deeptech combinant l'intelligence artificielle et l'apprentissage automatique.

1 articles liés à cet acteur

Research project looks at AI for designing antibody fragments in female contraception

Research project looks at AI for designing antibody fragments in female contraception

INRAE is leading a consortium composed of IN-CELL-ART, MabSilico and the Italian university UNIMORE to develop biological products based on antibody f...

26/03/2021 Read more →
Logo ActuIA Logo ActuIA

Votre source d'information sur l'intelligence artificielle et ses avancées.

NAVIGATION

  • Mentions légales
  • Contact

SUIVEZ-NOUS

© 2019-2025 Net Square Digital. Tous droits réservés.